Megakaryocytic Progenitor Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Megakaryocytic Progenitor Cells, covering 2014-09-16 to 2014-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia [Phase 2, Phase 3]